How to Get Kanuma (Sebelipase Alfa) Covered by UnitedHealthcare in Texas: Complete Prior Authorization and Appeals Guide
Quick Answer: Getting Kanuma Approved by UnitedHealthcare in Texas
Kanuma (sebelipase alfa) requires prior authorization from UnitedHealthcare/OptumRx for lysosomal acid lipase deficiency (LAL-D). Success depends on: confirmed LAL-D diagnosis (enzyme assay or genetic testing), documented disease severity (elevated liver enzymes, dyslipidemia), and evidence that supportive therapies are insufficient. First step: Have your specialist submit the Texas Standard PA Request Form with complete diagnostic documentation. If denied: Request peer-to-peer review and file internal appeal within 180 days. Texas residents can access independent external review through TDI if internal appeals fail.
Table of Contents
- Coverage Requirements at a Glance
- Step-by-Step: Fastest Path to Approval
- Required Documentation
- Common Denial Reasons & Solutions
- Appeals Process in Texas
- Cost Support Options
- When to Escalate
- Frequently Asked Questions
Coverage Requirements at a Glance
| Requirement | What UnitedHealthcare Needs | Where to Find It | Source |
|---|---|---|---|
| Prior Authorization | Required for all LAL-D patients | OptumRx formulary documents | UHC Enzyme Replacement Policy |
| Formulary Status | Specialty tier, no step therapy | Plan documents | OptumRx Formularies |
| Diagnosis Proof | LAL enzyme activity <10% normal OR LIPA gene variants | Lab reports | UHC Coverage Criteria |
| Specialist Requirement | Metabolic specialist, hepatologist, or geneticist | Provider credentials | UHC Policy |
| Site of Care | Specialty pharmacy + infusion center | Network directory | UHC Provider Admin Drugs |
| Appeals Deadline | 180 days from denial | Denial letter | Texas Standard PA Form |
Step-by-Step: Fastest Path to Approval
1. Confirm Diagnosis and Gather Evidence
Who: Your specialist (hepatologist, geneticist, or metabolic specialist) Timeline: 1-2 weeks What to collect:
- LAL enzyme activity assay showing <10% normal activity
- LIPA genetic testing results (if available)
- Recent liver function tests (ALT, AST, GGT)
- Complete lipid panel
- Liver imaging (ultrasound or MRI)
2. Document Disease Severity and Prior Treatments
Who: Your medical team Timeline: 1 week Required documentation:
- Evidence of hepatic involvement (elevated transaminases, hepatomegaly)
- Lipid abnormalities (elevated LDL-C, low HDL-C)
- History of supportive treatments tried (statins, dietary modifications)
- Growth charts (for pediatric patients)
3. Submit Texas Standard PA Request
Who: Prescribing specialist How: Texas Standard PA Form via UHC provider portal Timeline: Submit within 72 hours of gathering documentation Mark urgent if delay could jeopardize health
4. Follow Up on Decision
Timeline: 72 hours for standard requests, 24 hours for urgent Next steps: If approved, coordinate with specialty pharmacy. If denied, immediately request peer-to-peer review.
Required Documentation
Core Clinical Evidence
Diagnostic Confirmation
- LAL enzyme assay: Must show markedly reduced activity (<5-10% of normal range)
- Genetic testing: Pathogenic or likely pathogenic LIPA gene variants
- Clinical phenotype: Compatible symptoms and lab findings
Disease Severity Markers
- Liver involvement: ALT ≥1.5× upper limit of normal, hepatomegaly on imaging
- Lipid abnormalities: Elevated LDL-C, triglycerides; reduced HDL-C
- Growth/nutritional status: Especially important in pediatric cases
Medical Necessity Letter Checklist
Clinician Corner: Your medical necessity letter should address each of these points with specific patient data and citations to FDA labeling and UHC's own enzyme replacement policy.
- Confirmed LAL-D diagnosis with specific test results
- Evidence of active disease (elevated enzymes, lipid abnormalities)
- Prior supportive treatments and their limitations
- Why Kanuma is the only disease-modifying therapy available
- Expected clinical benefits and monitoring plan
- Dosing rationale consistent with FDA labeling
Common Denial Reasons & Solutions
| Denial Reason | How to Overturn | Documentation Needed |
|---|---|---|
| "Insufficient diagnostic evidence" | Submit complete enzyme assay and/or genetic testing | Lab reports with reference ranges, genetic counselor interpretation |
| "Lack of medical necessity" | Demonstrate disease severity and inadequate response to supportive care | Serial liver function tests, lipid panels, imaging showing progression |
| "Missing specialist evaluation" | Ensure PA submitted by appropriate subspecialist | Metabolic specialist, hepatologist, or geneticist consultation notes |
| "Exceeds quantity limits" | Provide weight-based dosing calculation per FDA label | Patient weight, dose calculation, vial requirements |
| "Alternative treatments not tried" | Document supportive care attempts and limitations | Treatment history with statins, dietary modifications, outcomes |
Appeals Process in Texas
Internal Appeals with UnitedHealthcare
Level 1: Reconsideration/Peer-to-Peer
- Timeline: Request within 30 days of denial
- Process: Call UHC provider services to arrange peer-to-peer with medical director
- Preparation: Have clinical summary, lab values, and treatment rationale ready
Level 2: Formal Internal Appeal
- Who can file: Patient, provider, or authorized representative
- Deadline: 180 days from denial notice
- Submission: Via UHC member portal or mail (address in denial letter)
- Decision timeline: 30 days for pre-service appeals
Texas External Review (Independent Review Organization)
If UnitedHealthcare's internal appeals are exhausted:
- Eligibility: Denials based on medical necessity or experimental/investigational status
- Filing deadline: 4 months from final internal denial
- Timeline: 20 days for standard review, 72 hours for urgent cases
- Cost: $25 filing fee (often waived for financial hardship)
- Binding decision: UnitedHealthcare must comply if IRO overturns denial
Contact Information:
- Texas Department of Insurance: 1-800-252-3439
- IRO Information Line: 1-866-554-4926
- Office of Public Insurance Counsel: 1-877-611-6742
Cost Support Options
Manufacturer Assistance
Alexion Access Navigator Program
- Financial assistance for eligible patients
- Prior authorization support and appeals assistance
- Contact: Visit alexionaccessnavigator.com or call program directly
Foundation Support
- National Organization for Rare Disorders (NORD): Patient assistance programs
- HealthWell Foundation: May offer copay assistance for rare disease treatments
- Patient Access Network Foundation: Copay support programs
Tip: Apply for manufacturer and foundation support simultaneously with your PA submission. Processing times can overlap, and having backup funding secured strengthens your case.
When to Escalate
Contact Texas regulators if:
- UnitedHealthcare misses decision deadlines (72 hours standard, 24 hours urgent)
- Appeal rights are not properly explained
- External review access is denied or obstructed
- You suspect the denial violates Texas insurance law
Texas Department of Insurance Consumer Protection
- Phone: 1-800-252-3439
- Online complaint system available
- Investigate insurer compliance with PA and appeals requirements
Frequently Asked Questions
How long does UnitedHealthcare prior authorization take in Texas? Standard PA decisions are typically made within 72 hours of complete submission. Urgent requests marked by the prescriber are decided within 24 hours.
What if Kanuma is non-formulary on my plan? Kanuma is typically covered on UnitedHealthcare/OptumRx formularies as a specialty drug. If it appears non-formulary, request a formulary exception using the Texas Standard PA Form.
Can I request an expedited appeal? Yes. Both internal appeals and Texas external reviews can be expedited if delay would seriously jeopardize your health. Your prescriber must certify the urgency.
Does step therapy apply to Kanuma? No. UnitedHealthcare's policies recognize that Kanuma is the only FDA-approved enzyme replacement therapy for LAL-D, so no step therapy against another ERT is required. However, you may need to document that supportive treatments (statins, dietary modifications) are insufficient.
What happens if I move from another state to Texas? Texas residents have stronger external review rights than many states. If you had a denial in another state, you can request a new PA in Texas and potentially access the Texas IRO process if denied.
How often do I need reauthorization? Most UnitedHealthcare policies require reauthorization every 6-12 months, with evidence of clinical response (improved liver enzymes, lipid levels, or stabilized disease progression).
About Counterforce Health
Counterforce Health helps patients, clinicians, and specialty pharmacies get prescription drugs approved by turning insurance denials into targeted, evidence-backed appeals. Our platform analyzes denial letters, plan policies, and clinical notes to identify the specific denial basis and draft point-by-point rebuttals aligned to each payer's own rules. For complex cases like LAL-D enzyme replacement therapy, we pull the right clinical evidence and weave it into appeals that meet procedural requirements while tracking deadlines and required documentation.
Sources & Further Reading
- UnitedHealthcare Enzyme Replacement Therapy Policy
- Texas Standard Prior Authorization Request Form
- FDA Kanuma Prescribing Information
- OptumRx Prior Authorization FAQ
- Texas Department of Insurance Consumer Resources
Disclaimer: This guide provides general information about insurance coverage and appeals processes. It is not medical advice or a guarantee of coverage. Always consult with your healthcare provider about treatment decisions and contact your insurance plan directly for specific coverage questions. Texas insurance regulations and UnitedHealthcare policies may change; verify current requirements with official sources.
Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.